InsidersTradesSigma
Follow the TheraCryf plc share price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are listed on UK GB, under the authority of RNS (LSE). The latest transaction was filed on 16 October 2025 (Purchase). Among the most active insiders: Edward James Norman Wardle. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
TheraCryf plc is a publicly traded company on the London Stock Exchange, focused on developing innovative therapeutic solutions. It specializes in the research and commercialization of treatments for various chronic diseases.